Work

Mental health diagnosis and medication changes after initiation of elexacaftor/tezacaftor/ivacaftor

Year: 2025

Type: article

Study design: Observational Study

Source: Annals of the American Thoracic Society

DOI: 10.1513/annalsats.202505-552oc

Authors: Cameron J McKinzie, Casey R Tak, Stephanie Duehlmeyer, Sarah Foushee, Suzan Hua, Morgan C Jones, Rebecca S Pettit, Yi Shi, Emma M Tillman, Brittany A Wright, Charissa W Kam

Institutions: University of North Carolina at Chapel Hill, University of North Carolina Health Care, University of North Carolina Hospitals, University of Utah, Children's Mercy Hospital, University of Louisville Hospital, University of California Davis Medical Center, UC Davis Health, University of California, Davis, Indiana University Health, Riley Hospital for Children, Indiana University School of Medicine, University of Iowa Hospitals and Clinics, University of Iowa Health Care

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Cystic Fibrosis Foundation

Award: G6734061260

OpenAlex ID: W4415629963

FWCI:

Cites: 19

Cited by:

Related to: